Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haematologic Disease (Cancer)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06503107
What this trial is testing

Nanobody-based Biepitope CAR-T Cells Targeting BCMA in the Treatment of R/RMM

Who this might be right for
Multiple Myeloma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60
Testing effectiveness (Phase 2)Study completedNCT01016600
What this trial is testing

Azacitidine and Lenalidomide for Acute Myeloid Leukemia

Who this might be right for
Leukemia, Myeloid, Acute
Washington University School of Medicine 31
Early research (Phase 1)Study completedNCT02316964
What this trial is testing

Decitabine, Donor Natural Killer Cells, and Aldesleukin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+5 more
Sumithira Vasu 8
Testing effectiveness (Phase 2)UnknownNCT05918198
What this trial is testing

Clinical Study of Venetoclax Combined With CAG in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Peking University People's Hospital 52
Testing effectiveness (Phase 2)Looking for participantsNCT07107529
What this trial is testing

Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.

Who this might be right for
Multiple Myeloma (MM)
European Myeloma Network B.V. 150
Early research (Phase 1)Looking for participantsNCT07130695
What this trial is testing

Olutasidenib Single Plus Combo Therapy in IDH1mut AML After Induction and Consolidation

Who this might be right for
Acute Myeloid Leukemia
Virginia Commonwealth University 15
Not applicableStudy completedNCT06655181
What this trial is testing

Evaluating the Effectiveness of Respiratory Muscle Training in Pediatric Kidney Transplant Patient

Who this might be right for
Chronic Kidney Disease(CKD)Pediatric ALLPediatric Kidney Transplantation+1 more
Atlas University 30
Post-approval studies (Phase 4)Study completedNCT07105319
What this trial is testing

Ropeginterferon for Treatment Free Remission

Who this might be right for
CML (Chronic Myelogenous Leukemia)
Dong-Wook Kim 65
Large-scale testing (Phase 3)UnknownNCT04446130
What this trial is testing

Study of Decitabine Combined With HAAG Regimen in Newly Diagnosed ETP-ALL/LBL, T/M-MPAL and ALL/LBL With Myeloid or Stem Cell Markers Patients

Who this might be right for
Induction ChemotherapyAcute T-Lymphocytic LeukemiaT-cell Lymphoblastic Lymphoma Leukemia+1 more
The First Affiliated Hospital of Soochow University 100
Testing effectiveness (Phase 2)Looking for participantsNCT07108530
What this trial is testing

Efficacy of Integrated Induction-Consolidation Chemotherapy and Transplantation for Adult Acute Myeloid Leukemia: Multicenter Study

Who this might be right for
Acute Myeloid Leukemia
Shanxi Bethune Hospital 50
Large-scale testing (Phase 3)Ended earlyNCT00630565
What this trial is testing

Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Masonic Cancer Center, University of Minnesota 12
Not applicableLooking for participantsNCT02682667
What this trial is testing

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

Who this might be right for
Multiple MyelomaLymphoma, Non-HodgkinLeukemia-Lymphoma, Adult T-Cell+2 more
National Cancer Institute (NCI) 500
Not applicableStudy completedNCT05169307
What this trial is testing

CPX-351 Real-World Effectiveness and Safety Study

Who this might be right for
Acute Myeloid Leukemia
Jazz Pharmaceuticals 147
Early research (Phase 1)Looking for participantsNCT06375044
What this trial is testing

Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Jiangsu Simcere Pharmaceutical Co., Ltd. 130
Large-scale testing (Phase 3)Ended earlyNCT00083564
What this trial is testing

Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Poniard Pharmaceuticals 240
Early research (Phase 1)Ended earlyNCT04855136
What this trial is testing

Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 21
Not applicableNot Yet RecruitingNCT07396571
What this trial is testing

Predictive Score in Patients With Hematological Malignancies Colonized by Multidrug-resistant Enterobacteriaceae

Who this might be right for
Hemato-oncologic PatientsColonizationNeutropenia+2 more
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 535
Very early researchUnknownNCT06277011
What this trial is testing

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research

Who this might be right for
Acute Lymphoblastic LeukemiaNon-hodgkin Lymphoma
Anhui Provincial Hospital 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT05231629
What this trial is testing

Sequential Therapy in Multiple Myeloma Guided by MRD Assessments

Who this might be right for
Multiple Myeloma
University of Alabama at Birmingham 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT00392353
What this trial is testing

Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia

Who this might be right for
Acute Erythroid LeukemiaAcute Megakaryoblastic LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome+6 more
National Cancer Institute (NCI) 135
Next Page